AMFI - Registered Mutual Fund Distributor

Corona Remedies Limited IPO

Corona Remedies Limited IPO

₹ 14868 / 14 Shares Shares
Minimum Investment

Corona Remedies Limited IPO

Issues Price

₹1008-1062 per equity share

Corona Remedies Limited IPO

Open Date

08 Dec 2025

Close Date

10 Dec 2025

Lot Size

14

Min. Investment

₹ 14868

Issue Price

₹1008-1062

Listing Date

15 Dec 2025

Issues Size

61,71,101 shares(aggregating up to ₹655.37 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

14 Shares

Offered To Public

14 Shares

Corona Remedies Limited IPO

Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women's healthcare, cardiology, pain management, urology, and other therapeutic areas. The diversified portfolio of the company as of December 2024 comprises 67 brands across therapeutic areas such as women's healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals, including vitamins/minerals/nutrition, gastrointestinal, and respiratory.The company has a pan-India marketing and distribution network with 2,598 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, thus consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas. Presently, the company owns two manufacturing facilities located in the states of Gujarat. As of December 31, 2024, the company had 88 R&D employees.

Founded In

2004

Managing Director

Dr. Kirtikumar Laxmidas Mehta

Parent Organization

Corona Remedies Limited IPO

Application Details of Corona Remedies Limited IPO.

Apply as Price Range Apply Upto
Retail (min) ₹1008-1062 ₹14,868
Retail(max) ₹1008-1062 ₹1,93,284
SHNI(min) ₹1008-1062 ₹2,08,152
SHNI(max) ₹1008-1062 ₹9,96,156
BHNI(min) ₹1008-1062 ₹10,11,024

For Corona Remedies Limited IPO, eligible investors can apply as Regular.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

4.6 Out of 5 (10926 Reviews)

KSquare helped me plan my retirement with complete clarity. The SIP guidance was simple, personalised, and stress-free. I now feel financially confident about my future and family responsibilities.

Rohit Sharma

Rohit Sharma

KSquare stands out with their personalized approach to NRI investing. Their team’s insights and professionalism are unmatched.

Neel Sharma

Neel Sharma

Real Estate Analyst

For long-term stability, I trust KSquare’s NPS guidance. Their regular insights and personal approach are top-notch.

Anuj Rastogi

Anuj Rastogi

Geologist

KSquare offered me a quick solution when I needed funds. They made the loan process easy to understand and access.

Sneha Dugar

Sneha Dugar

Academic Counselor

KSquare keeps my investments organized and stress-free. Their mutual fund options match my goals, and I appreciate the real-time tracking and timely updates.

Sameer Kapoor

Sameer Kapoor

Telecom Engineer

Investing used to feel complicated, but KSquare’s SIP process made it simple and stress-free. Now I save monthly without thinking twice.

Shruti Verma

Shruti Verma

Clinical Psychologist

KSquare offered everything I needed to invest from the UK. Their NRI Corner is efficient, clear, and built with trust.

Rhea Menon

Rhea Menon

Fashion Designer

Quick approvals, low documentation, and expert help—KSquare’s loan service is ideal for anyone needing funds quickly.

Priyanka Seth

Priyanka Seth

Fashion Designer

Getting a loan against my mutual funds was hassle-free with KSquare. Very professional and transparent experience.

Rohit Verma

Rohit Verma

Marketing Consultant

KSquare really simplified the NPS process for me. I appreciate their educational approach and helpful customer support.

Kavita Iyer

Kavita Iyer

Biology Lecturer

FAQ's

Frequenlty Asked Question

Is NPS a market-linked investment?

Yes, NPS invests in equity and debt instruments, so returns vary with market performance over time.

How are NPS returns calculated?

NPS returns depend on the performance of the equity, corporate debt, and government bond funds you select within your portfolio.

Can I nominate someone for my NPS account?

Yes, nomination is mandatory and can be easily added or updated through your KSquare profile.

Can I withdraw my mutual fund investment anytime?

Most mutual funds offer liquidity, allowing you to redeem units anytime, except for closed-ended and ELSS funds with lock-ins.

Are mutual funds taxable in India?

Yes, mutual funds are subject to capital gains tax. Taxation depends on the type of fund and holding period.

Can I use LAMF for personal or business purposes?

Yes, the loan can be used for any legal personal or business need such as emergencies, education, or working capital.

How does KSquare help with mutual fund selection?

KSquare uses algorithms, market insights, and advisor expertise to recommend funds suited to your goals and risk level.

What documents are needed for applying LAMF?

Basic KYC documents, bank statements, and demat account details are required. KSquare helps with digital submission.

App Store

Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.